Sinovac’s Pioneering EV71 Vaccine Set To Reach First Market
This article was originally published in PharmAsia News
The China FDA has given a production nod to Beijing Sinovac for its EV71 vaccine, which now appears set to be the first product of its type globally to be commercialized. The company expects to launch the vaccine in June and is also actively seeking partners in other Asian countries.
Register for our free email digests: